Letrozole Is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-5221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Comparison of Letrozole and Anastrozole Followed by Letrozole in Breast Cancer Patients

Breast Cancer: Targets and Therapy
Oncology
2015English

Is Letrozole Needed for Controlled Ovarian Stimulation in Patients With Estrogen Receptor-Positive Breast Cancer?

Gynecological Endocrinology
GynecologyEndocrinologyMetabolismObstetricsDiabetes
2013English

Effects of Switching From Anastrozole to Letrozole, Due to Reimbursement Policy, on the Outcome of Breast Cancer Therapy

Breast Cancer: Targets and Therapy
Oncology
2014English

Endogenous Estrogen, Testosterone and Progesterone Levels in Relation to Breast Cancer Risk

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2007English

Anastrozole May Aid Breast Cancer Prevention

Cancer Discovery
Oncology
2013English

Pictilisib Plus Anastrozole Reduces Proliferation in ER+ Breast Cancer

Cancer Discovery
Oncology
2016English

Plasma Matrix Metalloproteinase 2 Levels and Breast Cancer Risk

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2015English

Estrogen Metabolism and Breast Cancer

Cancer Letters
Cancer ResearchOncology
2015English

Inhalation Delivery of Topotecan Is Superior to Intravenous Exposure for Suppressing Lung Cancer in a Preclinical Model

Drug Delivery
MedicinePharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy